Murae Organisor Limited

EARUM

INE060601023

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:58 2024-07-12 am EDT			5-day change	1st Jan Change
1.59 ^INR	+0.63%		-4.79%	+38.26%

Jun. 29	Murae Organisor Limited announces tranche update	CI
Jun. 29	Murae Organisor Limited announced that it has received INR 514.999999 million in funding from IFL Enterprises Limited, Moneystar Tradelink Private Limited, Banke Tradelink Private Limited, Balmukund Tradelink Private Limited, Someshwara Tradelink Private Limited and other invetsors	CI

Earum Pharmaceuticals Limited Announces Resignation of Vijaykumar Patel as Managing Director

January 19, 2024 at 06:39 am EST

Earum Pharmaceuticals Limited announced the resignation of Vijaykumar Patel as Managing Director of the Company w.e.f 19th January 2024. Due to pre-occupation elsewhere, Vijaykumar is not in a position to devote time to the
affairs of the Company. Accordingly, he is submitting resignation as a Managing director of the Company with effect from 19th January, 2024.

Latest news about Murae Organisor Limited

Murae Organisor Limited announces tranche update	Jun. 28	CI
Murae Organisor Limited announced that it has received INR 514.999999 million in funding from IFL Enterprises Limited, Moneystar Tradelink Private Limited, Banke Tradelink Private Limited, Balmukund Tradelink Private Limited, Someshwara Tradelink Private Limited and other invetsors	Jun. 28	CI
Murae Organisor Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 30	CI
Murae Organisor Limited announces tranche update	May. 28	CI
Murae Organisor Limited Announces Board Appointments	Apr. 24	CI
Murae Organisor Limited Appoints Sangita Rajpurohit as Company Secretary and Compliance Officer	Apr. 04	CI
Earum Pharmaceuticals Limited Approves Board Resignations	Mar. 15	CI
Earum Pharmaceuticals' CFO Resigns	Feb. 12	MT
Earum Pharmaceuticals Limited Announces Resignation of Sunil Kumar Patel as Chief Financial Officer	Feb. 10	CI
Earum Pharmaceuticals Limited Approves Appointment of Vaghasiya Brijeshkumar Mathurbhai as Chief Financial Officer	Feb. 09	CI
Earum Pharmaceuticals Limited Announces Change in Corporate Office Address	Feb. 09	CI
Earum Pharmaceuticals Limited Announces Resignation of Sanjaykumar Nai as Non-Executive Director	Jan. 19	CI
Earum Pharmaceuticals Limited Announces Resignation of Vijaykumar Patel as Managing Director	Jan. 19	CI
Murae Organisor Names Managing Director	Jan. 05	MT
Earum Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Dec. 09	CI
Earum Pharmaceuticals Limited Approves Board Changes	23-08-23	CI
Earum Pharmaceuticals Names CFO	23-08-15	MT
Earum Pharmaceuticals Limited Appoints Sunilkumar Patel as Chief Financial Officer	23-08-14	CI
Earum Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Earum Pharmaceuticals CFO Departs	23-08-09	MT
Earum Pharmaceuticals Limited Announces Executive Changes	23-08-09	CI
Earum Pharmaceuticals Limited Announces Change of Registered Office	23-08-09	CI
Payal Patel Resigns as Chief Financial Officer of Earum Pharmaceuticals Limited	23-08-09	CI
Earum Pharmaceuticals Limited Announces Resignation of Directors	23-08-08	CI
Earum Pharmaceuticals Limited Announces Resignation of Madhuri Mistry from the Position of the Company Secretary	23-08-02	CI

Chart Murae Organisor Limited

Duration

Period

More charts

Company Profile

Murae Organisor Limited, formerly Earum Pharmaceuticals Limited, is an India-based pharmaceutical company. The Company is primarily engaged in marketing, trading and distribution of a range of pharmaceutical formulation products, such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/ anti-pyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by it under its own brand name. It also deals in the trading of active pharmaceutical ingredients (APIâs). Its products include HYGNEX+, HYGNEX+ Spray, EROLON and HYGNEX. It carries its business operations in Indian States, such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan and others.

Sector

Pharmaceuticals

Calendar

2024-07-28 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MURAE ORGANISOR LIMITED	+38.26%	4.7M
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
ROCHE HOLDING AG	+4.21%	230B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B